Medical Developments International Stock Performance
| MDDVF Stock | USD 0.30 0.01 3.23% |
The company secures a Beta (Market Risk) of -0.0972, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Medical Developments are expected to decrease at a much lower rate. During the bear market, Medical Developments is likely to outperform the market. At this point, Medical Developments has a negative expected return of -0.0977%. Please make sure to verify Medical Developments' information ratio, as well as the relationship between the kurtosis and day typical price , to decide if Medical Developments performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Medical Developments International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Medical Developments is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 36.3 M | |
| Total Cashflows From Investing Activities | -5.2 M |
Medical |
Medical Developments Relative Risk vs. Return Landscape
If you would invest 32.00 in Medical Developments International on September 29, 2025 and sell it today you would lose (2.00) from holding Medical Developments International or give up 6.25% of portfolio value over 90 days. Medical Developments International is currently producing negative expected returns and takes up 0.5527% volatility of returns over 90 trading days. Put another way, 4% of traded pink sheets are less volatile than Medical, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Medical Developments Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medical Developments' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Medical Developments International, and traders can use it to determine the average amount a Medical Developments' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1768
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MDDVF |
Based on monthly moving average Medical Developments is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medical Developments by adding Medical Developments to a well-diversified portfolio.
Medical Developments Fundamentals Growth
Medical Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Medical Developments, and Medical Developments fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medical Pink Sheet performance.
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0787 | |||
| Profit Margin | (0.55) % | |||
| Operating Margin | (0.54) % | |||
| Current Valuation | 80.17 M | |||
| Shares Outstanding | 86.31 M | |||
| Price To Book | 2.97 X | |||
| Price To Sales | 6.75 X | |||
| Revenue | 22.37 M | |||
| EBITDA | (12.86 M) | |||
| Cash And Equivalents | 28.27 M | |||
| Cash Per Share | 0.40 X | |||
| Total Debt | 2.93 M | |||
| Debt To Equity | 0.05 % | |||
| Book Value Per Share | 0.80 X | |||
| Cash Flow From Operations | (10.78 M) | |||
| Earnings Per Share | (0.18) X | |||
| Total Asset | 92.22 M | |||
About Medical Developments Performance
By analyzing Medical Developments' fundamental ratios, stakeholders can gain valuable insights into Medical Developments' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Medical Developments has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medical Developments has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Medical Developments International Limited manufactures and distributes pharmaceutical and veterinary products, and medical devices. The company was incorporated in 2003 and is headquartered in Scoresby, Australia. Medical Developments operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 68 people.Things to note about Medical Developments performance evaluation
Checking the ongoing alerts about Medical Developments for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Medical Developments help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medical Developments generated a negative expected return over the last 90 days | |
| Medical Developments has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 22.37 M. Net Loss for the year was (12.41 M) with profit before overhead, payroll, taxes, and interest of 15.63 M. | |
| Medical Developments International has accumulated about 28.27 M in cash with (10.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 29.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Medical Developments' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medical Developments' stock is overvalued or undervalued compared to its peers.
- Examining Medical Developments' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medical Developments' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medical Developments' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medical Developments' pink sheet. These opinions can provide insight into Medical Developments' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Medical Pink Sheet analysis
When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |